Translate EU AI Act Article 50 transparency requirements into format-specific marketing controls for text, images, audio, video and direct AI interactions.
Short answer: Implement Article 50 through a format-specific control matrix: classify whether the organisation is a provider or deployer, identify the content or interaction in scope, add the required machine-readable mark where applicable, present a clear human-facing disclosure at the appropriate moment, preserve that treatment through distribution, and retain evidence. Legal review must resolve exceptions and jurisdiction-specific facts.
A single “made with AI” footer is not an implementation system. The relevant role, content type, level of manipulation, distribution context and audience experience can differ across a chatbot, paid image, narrated article, synthetic presenter and public-interest text. The label also has to survive export, resizing, transcoding, syndication and platform ingestion.
CDM’s deployment matrix turns the legal classification into production controls. It keeps four questions separate: what the official rule says, what counsel decides is in scope, what the workflow must do, and what evidence proves the treatment reached the published asset. This article describes an operating method, not a legal conclusion for a particular campaign.
What the official evidence establishes
The European Commission’s Article 50 transparency guidance says the provision applies from 2 August 2026. It describes duties that include informing people when they interact directly with certain AI systems, machine-readable marking by providers for AI-generated or manipulated content, and disclosure by deployers for specified categories such as deepfakes and certain public-interest text.
The Commission also explains that roles and exceptions matter and that the accompanying guidance and code address practical compliance. That means a marketer cannot decide the treatment from file format alone. The organisation’s role, the generation or manipulation activity, editorial control and publication context require documented analysis.
For provenance technology, the current C2PA specification defines standards for recording media source and history. C2PA may help carry machine-readable provenance, but a credential is not automatically the complete Article 50 treatment and does not prove the media’s claim is true.
The CDM Article 50 Mark-and-Label Deployment Matrix
Complete one row per asset or interaction. Counsel owns scope classification; product and creative teams own implementation; publishing operations proves survival; the business owner accepts residual risk.
| Surface | Classification questions | Human-facing control | Machine/workflow control |
|---|---|---|---|
| Interactive AI | Is the person directly interacting with an AI system, and is it otherwise obvious? | Plain disclosure before or at the start of interaction | Versioned interface state, locale test and interaction log |
| Image | Generated or materially manipulated? Deepfake or ordinary editing? | Proximate label where the applicable rule and context require it | Durable provenance/mark, export and platform-survival test |
| Audio | Synthetic voice, altered recording or routine clean-up? | Audible or visible disclosure suited to the listening context | File-level mark, transcript note and re-encode test |
| Video | Synthetic person/event, edited scene or standard production effect? | On-screen or otherwise clear disclosure at the relevant viewing point | Manifest/mark, caption metadata and transcode test |
| Text | Public-interest publication, human review and editorial control? | Clear notice where counsel determines required or trust-relevant | Authorship/review status, model-use record and publication metadata |
| Derivative / syndication | Will a partner crop, strip metadata, dub or summarise? | Contracted and rendered disclosure in each downstream format | Delivery specification, acceptance test and exception log |
How to run the Article 50 Mark-and-Label Deployment Matrix
1. Map role and distribution
Record who provides the AI system, who deploys it, who creates the asset and who publishes it. List EU audience exposure, channels, languages and downstream partners. Do not assume the party paying for production controls every legal role or technical step.
2. Classify each transformation
Describe the source material and the AI operation: generation, replacement, cloning, synthesis, enhancement, translation, routine correction or another change. Preserve input/output examples. Counsel should decide the applicable category and exception; the creative team should not compress that decision into “AI used: yes/no”.
3. Design the human disclosure
Place the disclosure where the audience encounters the synthetic or interactive experience, using language people can understand. Test timing, prominence, contrast, audio audibility, mobile layout, captions and localised versions. A hidden policy page is weak evidence that a person was informed at the relevant moment.
4. Implement the machine-readable treatment
Apply the method approved for the asset and workflow. Record the tool, specification/version, credential or mark identifier and export settings. Test that routine editing, optimisation, content delivery and platform upload do not silently strip it. Where a platform removes metadata, implement the approved fallback and record the limitation.
5. Create a release gate
Require completed classification, counsel or policy decision, human disclosure proof, machine-mark verification where applicable, claim substantiation and downstream instructions before approval. The gate should block publication rather than create an advisory warning that teams routinely ignore.
6. Monitor and correct
Sample live assets across devices and platforms, especially after transcoding or partner reuse. Give viewers and staff a correction route. If a label is missing, contain distribution, restore the treatment, notify affected partners and document the cause. Review the matrix whenever Commission guidance or production tooling changes.
Decision rules
The matrix should never turn uncertain legal scope into a guessed checkbox. Escalate ambiguity and use trust-enhancing disclosure where it is accurate and does not misstate the legal basis.
| Signal | Decision | Evidence to retain |
|---|---|---|
| Role or scope cannot be determined | Hold release and obtain specialist analysis | Role map, asset description and counsel decision |
| Human disclosure is absent or not perceivable in the actual context | Hold or repair the rendered experience | Device, locale and accessibility test |
| Machine-readable mark is stripped during normal distribution | Use approved fallback and fix the pipeline before scale | Pre/post export and platform inspection |
| Partner cannot preserve the required treatment | Restrict delivery or amend the distribution method | Contract term, technical test and acceptance record |
| Content changes after approval | Reclassify the final asset; do not rely on the earlier sign-off | Final checksum/version and new approval |
Build the evidence record before launch
The evidence pack must show the asset that audiences actually received, not only the editable master. Keep a trace from source through each derivative.
- Provider/deployer role map, target territories and publication contexts.
- Source media, transformation description, model/tool and final asset version.
- Counsel or policy classification, applicable exception analysis and approver.
- Human-facing disclosure copy, timing, placement, localisation and accessibility tests.
- Machine-readable mark or provenance evidence and specification/version.
- Export, CDN, platform, syndication and re-encoding survival results.
- Correction route, monitoring sample, incident record and next review trigger.
Limit access to source media and personal data. The governance record can preserve hashes and controlled references instead of circulating sensitive originals. Retention should follow approved legal and records policies.
Separate fact, CDM inference and the operating decision
Documented fact
The Commission says Article 50 applies from 2 August 2026 and describes transparency duties for certain direct AI interactions and synthetic or manipulated content, with role- and context-specific detail.
CDM inference
A dual-layer control—human disclosure plus machine/workflow evidence—should be more resilient than a label added manually at the final publishing step, but survival must be tested in each distribution chain.
Operating decision
Do not publish an in-scope asset until role and scope are reviewed, the audience disclosure is perceivable, required machine treatment is verified in the live derivative, and correction ownership is assigned.
Worked example: a synthetic multilingual product video
A fictional retailer records a human product demonstration, generates a synthetic translation of the presenter’s voice and adjusts mouth movement for three EU-language versions. The campaign will run on the retailer’s site and a partner video platform. The team initially proposes one disclosure in the English description.
The matrix records separate final files, audiences, platform transformations and the synthetic audio/visual operations. Counsel determines the applicable treatment. Creative operations adds localised on-screen disclosure and approved machine-readable provenance to each master, then tests whether both survive export and platform processing.
One platform strips the provenance data during transcoding. The team does not claim technical compliance from the master alone; it records the limitation, applies the approved visible treatment, restricts an unsupported derivative and seeks specialist sign-off before release. The example illustrates the control method, not a legal interpretation.
Limitations and review boundary
Article 50 contains definitions, role distinctions and exceptions that this operational guide cannot resolve for every asset. EU and national guidance, enforcement practice and technical standards can change. Obtain qualified EU counsel and review the current official materials for each use case.
Machine-readable provenance can be removed or become unreadable, and visible labels can be cropped or separated from media. Neither proves the underlying message is accurate. Claim substantiation, endorsement rules, privacy, intellectual property and sector requirements remain separate controls.
Related guides
Frequently asked questions
Does every use of AI in marketing need an Article 50 label?Not necessarily. The applicable role, system, transformation, content and context matter, and exceptions may apply. Document the use and have qualified counsel determine scope rather than applying a universal AI-used label as a legal conclusion.
Is a C2PA Content Credential enough?Not by itself. It can carry provenance information, but the required transparency treatment depends on Article 50 scope and current guidance. Human-facing disclosure and workflow evidence may also be needed.
Where should a disclosure appear?At a point and in a form that is clear in the actual audience experience. Test the rendered page, audio, video, mobile view, captions and partner platform. The precise legal treatment requires specialist review.
What if a social platform removes metadata?Document the test, apply the approved fallback, preserve the visible treatment, and decide whether the platform can be used for that asset. Do not treat the marked master as proof of the published derivative.
Should human-reviewed AI-assisted text be labelled?That depends on the specific facts, content and applicable provisions. Record the AI and human editorial process, then obtain legal review. Voluntary disclosure can be considered separately from a claim that the law requires it.
Method and publication status
This prepublication draft was researched from the primary materials linked at the claims they support and checked on 12 October 2026. It requires the named specialist review, live-product retesting where indicated, a real 16:9 editorial image and final URL verification before publication. It is operational analysis, not legal, security or compliance advice.
This article is editorial guidance. Apply the principles in proportion to your market, evidence, and responsibilities.
